BMRN vs HUBS · P/E 40, rev $1.76B vs P/E 96, rev $1.79B
Biomarin Pharmaceutical Inc (BMRN) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the BMRN and HUBS stock pages for the full models.
Not investment advice.